Prognostic Stage IV Breast Cancer AJCC v8 Terminated Phase 2 Trials for Pembrolizumab (DB09037)

IndicationStatusPhase
DBCOND0109667 (Prognostic Stage IV Breast Cancer AJCC v8)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04190056Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast CancerTreatment